The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men
When:
Thursday, March 9, 2023
12:00 PM - 1:00 PM CT
Where: Robert H Lurie Medical Research Center, Hughes Auditorium, 303 E. Superior, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Public - Post Docs/Docs - Graduate Students
Contact:
Institute for Public Health and Medicine (IPHAM)
Group: Institute for Public Health and Medicine (IPHAM)
Category: Lectures & Meetings
Description:
**HYBRID EVENT: join us IN-PERSON or ONLINE. Please RSVP regardless and indicate your intended mode. The in-person event will be held in Hughes Auditorium of the Lurie Medical Research Building at 303 E. Superior; Chicago. Lunch will be provided for in person attendees on a first-come, first-served basis.**
Guest:
Adam B. Murphy, MD, MBA, MSCI
Assistant Professor of Urology & Preventive Medicine
Northwestern University Feinberg School of Medicine
Dr. Adam Murphy will summarize the results of a randomized controlled trial assessing the impact of a Genomic Assay on urologists and patients treatment preferences for favorable risk. prostate cancer.
For more public health news, events, and announcements, visit the IPHAM website: https://feinberg.northwestern.edu/ipham
This webinar is part of the Translational Applications in Public Health mini-series, which is a collaboration between the Institute for Public Health and Medicine (IPHAM) and the Northwestern University Clinical and Translational Sciences (NUCATS) Institute.